跳至主要内容
临床试验/NCT05478330
NCT05478330已完成不适用

Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris

Zagazig University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年1月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
changes in the number of comedones, papules, and pustules

研究概览

简要总结

From the obtained results, topical Flutamide 1% gel can be a promising, effective, and safe alternative in treating patients with acne vulgaris with minimal side effects.

详细描述

Flutamide is a non-steroidal anti-androgen, which is used to treat patients with prostate cancer. Due to its anti-androgenic properties can be used in cases of acne, hirsutism, and androgenic alopecia with successful outcomes. To minimize the unnecessary systemic side effects associated with the oral administration of Flutamide. It has been shown that the topical delivery of Flutamide can allow high drug levels at the site of action, decreasing the systemic side effects and improving patient compliance.

The Flutamide group received topical Flutamide 1% gel twice daily on the face for 8 weeks and the control group received the same gel components, without flutamide, twice daily on the face for 8 weeks

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Fifty adult patients with acne having inflammatory (papules and pustules) and non-inflammatory (comedones) of different sizes, distribution, and durations were included in this study.

排除标准

  • Patients with a history of acne treatment with systemic or topical antibiotics, retinoids, or hormonal therapy within the last 3 months.
  • Patients with a history of chronic renal failure, hepatic insufficiency

研究组 & 干预措施

Group A (Flutamide group)

Experimental

Flutamide was supplied in the form of yellow powder and obtained from Sigma Pharmaceutical Industries, Egypt.

Tween 80 and Propylene glycol were obtained from Sigma Pharmaceutical Industries, Egypt.

Oleic acid was purchased from El Gomhouria Company for Trading Chemicals and Medical Appliances, Egypt.

干预措施: Flutamide 1% gel (Drug)

Group B (control group)

Placebo Comparator

Tween 80 and Propylene glycol were obtained from Sigma Pharmaceutical Industries, Egypt.

Oleic acid was purchased from El Gomhouria Company for Trading Chemicals and Medical Appliances, Egypt.

干预措施: topical gel without flutamide (Drug)

结局指标

主要结局

changes in the number of comedones, papules, and pustules

时间窗: up to 8 weeks

Response to treatment was evaluated by the changes in the number of comedones, papules, and pustules and by a photographic comparison taken at Baseline ( before treatment) and at 2,4,6, and 8 weeks at (termination of therapy).

次要结局

  • side effects(8 weeks)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Reham Essam

Lecturer of Dermatology

Zagazig University

研究点 (1)

Loading locations...

相似试验